Caralluma fimbriata has been shown to inhibit pre-adipocyte cell division in a mouse cell study published in Food and Nutrition Sciences.
Brand name ingredient Slimaluma, an extract of Caralluma fimbriata, has been shown to inhibit pre-adipocyte cell division in a mouse cell study published in Food and Nutrition Sciences.
According to researchers, “CFE [Caralluma fimbriata extract] appears to inhibit pre-adipocyte cell division by interfering with a mechanism preceding the import of cyclin D1-CDk4/6 complex into the nucleus during the early G1 phase of the cell cycle, suggesting that CFE has the potential to inhibit hyperplastic obesity.”
They said that CFE inhibited 3T3-L1 cell growth in a dose- and duration-dependent manner, with the optimal dose appearing to be at or near 100 µm/ml. One of the researchers was Ramasamy Venkatesh of Gencor Nutrients (Anaheim, CA), the developer of Slimaluma.
Steve Mister on CRN's ongoing lawsuit against New York State
October 11th 2024Nutritional Outlook spoke to The Council for Responsible Nutrition's president and CEO, Steve Mister, at its annual meeting, Convergence '24. Mister discussed the latest in its ongoing lawsuit against NY State's law banning the sale of weight management and muscle building products to minors.